• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Cybersecurity Challenges Leave Medical Device Makers Insecure

    OEMs Are Demanding Designs that Challenge Suppliers

    Diabetes Technology Manufacturers Seemingly on a Sugar Rush

    Post-Pandemic Partnerships: A Full-Service Outsourcing Discussion

    Discovering the Value of Surface Treatments and Coatings for Medtech
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    Linear Health Sciences’ Orchid SRV Receives FDA & Health Canada Approval

    Vivasure Medical Raises $23 Million in Series D Financing Round

    New Patents Add Value to Know Labs' Bio-RFID Tech

    Ra Medical Granted Patent for Catheters With Expanded Ablation Area

    ReCor Medical Presents Data from Two Randomized Trials
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Cybersecurity Challenges Leave Medical Device Makers Insecure

    OEMs Are Demanding Designs that Challenge Suppliers

    Diabetes Technology Manufacturers Seemingly on a Sugar Rush

    Post-Pandemic Partnerships: A Full-Service Outsourcing Discussion

    Discovering the Value of Surface Treatments and Coatings for Medtech
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Injecting Neurostimulators into Blood Vessels (We Swear, It’s Not Sci-Fi)

    Understanding the Costs of Care in the OR

    Sick of Being Sick: Pandemic Fatigue Flares at AAOS

    Managing Critical Healthcare Supply Chains in Turbulent Times

    To Drive Value, Human Capital Leaders Turn to Outsourced Solutions
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Fusion Biotec Inc.

    Cirtec Medical

    Concise Engineering

    BMP Medical

    Arthur G. Russell Co. Inc., The
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    3D Printing in Dental Prosthodontics, Orthodontics, and Surgery

    What New Tech Can Improve Your Medical Manufacturing Plant?

    Why Medical Device Firms Must Navigate the Muddy Waters of ESG Requirements

    Medical Device Servicing vs. Remanufacturing

    Digital Marketplaces for Medical Equipment Come of Age
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Fusion Biotec Inc.

    Cirtec Medical

    Concise Engineering

    BMP Medical

    Arthur G. Russell Co. Inc., The
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Top30

    7. Danaher Corp.

    ...

    7. Danaher Corp.
    Related CONTENT
    • SCIEX Debuts the ZenoTOF 7600 System
    • COVID-19 Sample Collection Kits Market to Reach $16.56B by 2028
    • Rapid Medical Diagnostic Kits Market Size Worth $23.04 Billion By 2027
    • The Top 30 and M&A in 2021: What’s Next?
    • ZS Introduces AWS-Powered End-to-End Analytics Platform for Life Sciences Industry
    07.19.16
    $10.9 Billion

    KEY EXECUTIVES:
    Thomas P. Joyce, Jr., President and CEO
    Daniel L. Comas, Exec. VP and Chief Financial Officer
    William H. King, IV, Sr. VP, Strategic Development
    Daniel Raskas, Sr. VP, Corporate Development

    NUMBER OF EMPLOYEES: 81,000 (total)

    GLOBAL HEADQUARTERS: Washington, D.C.

    Danaher has a long history of growth through acquisitions. In fact, the company has made over 400 purchases since 1984 to enhance its offerings within its identified key focus business sectors. More recent buys that impacted its medical technologies footprint included Beckman Coulter Inc., a medical diagnostics manufacturer, for $5.87 billion in 2011, and Nobel Biocare Services AG, a then-leading provider of dental implants, for $2.2 billion in 2014. Both moves immediately positioned Danaher as a leader in these respective healthcare technology sectors.

    Following in the footsteps of those acquisitions, Danaher made one of its largest purchases in 2015. In May, it was announced that the company had agreed to buy Pall Corporation, a global provider of filtration, separation, and purification solutions for an array of industries, including many to which Danaher was already providing products. The purchase price for Pall was $13.8 billion; the company saw revenues in 2014 of $2.8 billion—$1.5 billion from the life sciences segment and $1.3 billion from industrial. While the life sciences sector of Pall primarily sold into the biopharmaceutical market, it also supplied medical device manufacturers. Given Danaher’s strength in the diagnostics technologies sector, synergies between the two must have been apparent.

    “Pall is a highly attractive business, with approximately 75 percent recurring revenues, mid-single digit organic growth, and a solid margin profile. Its best-in-class technology, combined with the broadest, most technically advanced solutions, make it the premier brand in the filtration industry,”  Thomas P. Joyce Jr., Danaher’s president and CEO said in a press release that initially announced the acquisition. “Pall will provide us a leading business with significant runway for expansion and strengthens our life sciences position in the strategically attractive, high-growth biopharmaceutical market. With the Danaher Business System as a foundation, Pall associates will have the tools to accelerate new product development and improve operational efficiency in the years to come. We look forward to welcoming the Pall team to Danaher.”

    In addition to the Pall purchase, Danaher acquired 11 other companies to further its capabilities across its five main business segments. In total, the company’s 2015 M&A activity significantly outpaced 2014’s moves (financially), which totaled more than $3 billion and 17 businesses, including Nobel Biocare. Company executives insist that its acquisition strategy will remain in place through 2016, but as of yet, there haven’t been any significant buys by Danaher since the Pall purchase. This may be due to the company’s strategy to split Danaher into two unique business entities—a science and technology focused growth company, and a diversified industrial firm.

    Danaher and Fortive
    In contrast to the consolidation trend among medical device OEMs that have firms growing rapidly while becoming a “one-stop-shop” to address a particular therapy application such as diabetes or orthopedics, this year’s Top 30 list features a number of examples of companies that are splitting into separate business entities. In several instances, where a company maintains dissimilar divisions that serve very different market segments, the company is going through a significant transformation to become two stand-alone entities. Danaher is yet another example of this trend.

    In what must have been the biggest news cycle for the company in its history, on the same day the Pall acquisition announcement was made, Danaher also made it known that it would separate to become two independent, publicly traded firms.

    Danaher would continue on to be the company name for the firm that executives described as “a science and technology growth company united by common business model characteristics, including significant recurring revenue and an attractive margin profile.” This entity would be made up of the Pall Corporation, along with the existing segments of life sciences and diagnostics, as well as dental. Rounding out this business would be the water quality and product identification platforms. The collective businesses posted approximately $16.5 billion in revenues in fiscal 2014.

    The then-unnamed spin-off firm (since launched under the name Fortive) would be made up of Danaher’s industrial divisions, providing offerings that address needs in test and measurement, retail fueling, telematics, and automation. These business units saw revenues of approximately $6 billion in fiscal 2014.

    “This is an exciting day for Danaher and an important step in our company’s history. Danaher has always been at its best when all platforms have the ability to invest in the highest impact organic growth opportunities, pursue meaningful acquisitions, and use the Danaher Business System to continuously improve performance,” Joyce said in the release that officially announced the split. “The pending strategic acquisition of Pall Corporation offers us the unique opportunity to drive greater shareholder value going forward as two stronger and better companies. Each company will be more focused with access to the capital necessary to pursue organic and inorganic growth opportunities. DBS will remain the foundation of both companies, allowing each to further strengthen their market leading positions while continuously improving growth, margins and cash flow.”

    Leading Danaher will continue to be Joyce as president and CEO and Daniel L. Comas, executive vice president and chief financial officer. At the helm of Fortis is President and CEO James A. Lico, formerly the executive vice president of the Danaher Test & Measurement and Gilbarco Veeder-Root businesses.

    “I am honored and humbled that the board has selected me to lead this new diversified industrial growth company,” Lico said in the announcement release. “As a standalone company, we will have the opportunity to pursue a more focused growth strategy with a renewed emphasis on M&A for many of these businesses. We have an outstanding team that will ensure this separation goes smoothly and that the company will continue to win in the markets in which we compete. I am committed to building and reinforcing the DBS culture and ensuring the company exceeds our customers, shareholders, and associates’ expectations.”

    Figures
    Regardless of the roller coaster ride that was 2015 for Danaher, with the start of a company split coupled with bringing a substantial acquisition into the fold (not to mention the incorporation of the other 11 company buys that were also brought aboard), numbers looked good for the business. Sales in 2015 (year ended Dec. 31) for medical device related businesses (life sciences & diagnostics, and dental) were $10.95 billion. This represented a 16.8 percent increase over 2014’s total for the same segments, which was $9.37 billion.

    Broken out separately, the life sciences & diagnostics sector was credited with sales of $8.21 billion, a 14.3 percent increase over the $7.19 billion reported in 2014. According to Danaher, this business sector offers analytical instruments, reagents, consumables, software, and services that hospitals, physicians’ offices, reference laboratories, and other critical care settings use to diagnose disease and make treatment decisions. It also includes the filtration products and capabilities of the acquired Pall Corporation. Part of the increase in sales was attributed to price increases. Strong demand in China and other high-growth regions for urinalysis and immunoassay consumable products was another contributor. Another factor behind the increase was consumable sales to support an installed base of blood gas instruments, primarily in China and the Middle East.

    The dental segment, which provides products used to diagnose, treat, and prevent disease and ailments of the teeth, gums, and supporting bone, as well as to improve the aesthetics of the human smile, saw even more dramatic growth. Sales in 2015 were $2.73 billion, a 25 percent increase over 2014’s $2.19 billion revenue. Again, a small portion of the increase can be attributed to price increases. The Nobel Biocare purchase in December 2014 had the greatest impact on sales, increasing the company’s overall dental line and providing new and complementary products and services. 
    Related Searches
    • hospitals
    • Automation
    • blood
    • medical device manufacturers
    Related Knowledge Center
    • Software & IT
    Suggested For You
    SCIEX Debuts the ZenoTOF 7600 System SCIEX Debuts the ZenoTOF 7600 System
    COVID-19 Sample Collection Kits Market to Reach $16.56B by 2028 COVID-19 Sample Collection Kits Market to Reach $16.56B by 2028
    Rapid Medical Diagnostic Kits Market Size Worth $23.04 Billion By 2027 Rapid Medical Diagnostic Kits Market Size Worth $23.04 Billion By 2027
    The Top 30 and M&A in 2021: What’s Next? The Top 30 and M&A in 2021: What’s Next?
    ZS Introduces AWS-Powered End-to-End Analytics Platform for Life Sciences Industry ZS Introduces AWS-Powered End-to-End Analytics Platform for Life Sciences Industry
    Danaher to Acquire Cepheid for $4 Billion Danaher to Acquire Cepheid for $4 Billion
    Beckman Coulter & Augusta University to Improve Patient Outcomes Beckman Coulter & Augusta University to Improve Patient Outcomes
    Looking Ahead Looking Ahead
    Medtech Supplier Consolidation, the Boeing Way Medtech Supplier Consolidation, the Boeing Way
    Senior Engineer – (TFF New Product Development) Senior Engineer – (TFF New Product Development)
    Danaher Buys Breast Biopsy Device Maker Devicor
Danaher Buys Breast Biopsy Device Maker Devicor
    Danaher Selects Next President and CEO Danaher Selects Next President and CEO
    Fluke Biomedical Buys Swedish X-Ray Firm Fluke Biomedical Buys Swedish X-Ray Firm
    JNJ Looks to Divest its Clinical Diagnostics Business JNJ Looks to Divest its Clinical Diagnostics Business
    NAMSA Opens Office in China NAMSA Opens Office in China

    Related Content

    • SCIEX Debuts the ZenoTOF 7600 System

      SCIEX Debuts the ZenoTOF 7600 System

      System delivers new capabilities for life science research and biotherapeutic development.
      Business Wire 09.02.21

    • COVID-19 Sample Collection Kits Market to Reach $16.56B by 2028

      COVID-19 Sample Collection Kits Market to Reach $16.56B by 2028

      Most lucrative growth to occur in Asia Pacific region.
      Polaris Market Research 06.28.21

    • Diagnostics
      Rapid Medical Diagnostic Kits Market Size Worth $23.04 Billion By 2027

      Rapid Medical Diagnostic Kits Market Size Worth $23.04 Billion By 2027

      A desire to provide rapid disease treatments is driving the market's growth.
      Michael Barbella, Managing Editor 02.09.21


    • The Top 30 and M&A in 2021: What’s Next?

      The Top 30 and M&A in 2021: What’s Next?

      With three of the top five companies appointing new CEOs in the last year and the global pandemic eroding earnings, M&A strategies could look a lot different.
      Florence Joffroy-Black and Dave Sheppard, MedWorld Advisors 11.04.20

    • ZS Introduces AWS-Powered End-to-End Analytics Platform for Life Sciences Industry

      ZS Introduces AWS-Powered End-to-End Analytics Platform for Life Sciences Industry

      Amazon Web Services- and big data-based platform deliver industry-tailored insights and advanced decision-making.
      ZS 05.24.17


      Breaking News
      • Linear Health Sciences’ Orchid SRV Receives FDA & Health Canada Approval
      • Vivasure Medical Raises $23 Million in Series D Financing Round
      • New Patents Add Value to Know Labs' Bio-RFID Tech
      • Ra Medical Granted Patent for Catheters With Expanded Ablation Area
      • ReCor Medical Presents Data from Two Randomized Trials
      View Breaking News >
      CURRENT ISSUE

      May 2022

      • Cybersecurity Challenges Leave Medical Device Makers Insecure
      • Contract Design for Medtech
      • Diabetes Medical Device Technology Update
      • Medtech Full-Service Outsourcing Q&A 2022

      Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
      You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

      • About Us
      • Privacy Policy
      • Terms And Conditions
      • Contact Us

      follow us

      Subscribe
      Nutraceuticals World

      Latest Breaking News From Nutraceuticals World

      Nootropics and Adaptogens Respond to Demand for Mind and Mood Support
      Sabinsa Honors 70th Anniversary of Diplomacy Between India and Japan
      Solvay Invests in Suanfarma’s Vanillin Production
      Coatings World

      Latest Breaking News From Coatings World

      DIC’s Indian Subsidiary Begins Construction of Coating Resins Production Facility
      Celanese Declares Force Majeure on Acetyl Chain and Acetate Tow Products
      CPI Announces New Hybrid Professional Development Program for 2022
      Medical Product Outsourcing

      Latest Breaking News From Medical Product Outsourcing

      Vivasure Medical Raises $23 Million in Series D Financing Round
      New Patents Add Value to Know Labs' Bio-RFID Tech
      Ra Medical Granted Patent for Catheters With Expanded Ablation Area
      Contract Pharma

      Latest Breaking News From Contract Pharma

      Evotec SE and Sernova Corp Announce Partnership in the Field of Diabetes
      Emergex COVID-19 Vaccine Candidate Successfully Coated onto Zosano Micro-Needle Patch
      Thabor Therapeutics Appoints Jérémie Mariau as CEO
      Beauty Packaging

      Latest Breaking News From Beauty Packaging

      Aveda is Leaping Bunny Approved by Cruelty Free International
      Bite Beauty Is Closing Later This Year
      Johnson & Johnson Names CEO & CFO of Planned Consumer Health Company
      Happi

      Latest Breaking News From Happi

      Selig Group Names Adam Sheridan Next President
      Nautica Introduces Oceans Pacific Coast Vegan & Sustainable Fine Fragrance Collection
      Dip Powder Nail Brand Nailboo, Expands Into Retail Exclusively At Sally Beauty
      Ink World

      Latest Breaking News From Ink World

      Nazdar Ink Technologies to Manufacture VFP Ink Technologies Electronic Inks for US
      Sun Chemical Heads to Flexo and Labels 2022
      PETRONAS Chemicals Group to Acquire Perstorp Group
      Label & Narrow Web

      Latest Breaking News From Label & Narrow Web

      Essentra Packaging invests in Landa Nanographic press
      Nazdar to manufacture VFP electronic ink for US Market
      SunDance moves into flexible packaging with HP Indigo
      Nonwovens Industry

      Latest Breaking News From Nonwovens Industry

      The Honest Company to Sell Diapers, Wipes at Walmart
      Jim Cree Joins Monadnock Nonwovens
      IFAI Members Approve Name Change
      Orthopedic Design & Technology

      Latest Breaking News From Orthopedic Design & Technology

      Paragon 28 Launches Grappler Suture Anchor System
      Paul Stellato Appointed Chief Accounting Officer at Zimmer Biomet
      DuPuy Synthes’ INHANCE Shoulder System Cleared by FDA for Reverse Total Shoulder Arthroplasty
      Printed Electronics Now

      Latest Breaking News From Printed Electronics Now

      Jabil Strengthens Additive Manufacturing Offerings
      Avery Dennison, Wiliot Partner to Build and Scale the Future of IoT
      HP Delivers Enhanced Platform Capabilities to Accelerate Additive Manufacturing Production at Scale

      Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

      AD BLOCKER DETECTED

      Our website is made possible by displaying online advertisements to our visitors.
      Please consider supporting us by disabling your ad blocker.


      FREE SUBSCRIPTION Already a subscriber? Login